1. Treating Myocardial Infarction in the Post-GUSTO Era

   • Menko-Jan de Boer
   • Felix Zijlstra

   Leading Article 10 November 2012 Pages: 427 - 437

2. Anaemia of Prematurity

   • Michael P. Meyer

   Review Article 10 November 2012 Pages: 438 - 445

3. The Costs of Epilepsy and Cost-Based Evaluations of Anticonvulsants

   • William G. Johnson

   Review Article 10 November 2012 Pages: 446 - 459

4. An Economic Evaluation of Tiludronic Acid Treatment in Paget’s Disease of Bone

   • Antoine Lafuma
   • Francis Fagnani
   • Pierre J. Meunier

   Original Research Article 10 November 2012 Pages: 460 - 474

5. Economic Evaluation of the Use of Nadroparin Calcium in the Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients in Italy

   • Adam Lloyd
   • Judith A. Aitken
   • Nicholas D. Barbe

   Original Research Article 10 November 2012 Pages: 475 - 485

6. The Impact of Parkinson’s Disease on Health Status, Health Expenditures, and Productivity

   • Linda M. Rubenstein
   • Elizabeth A. Chrischilles
   • Margaret D. Voelker

   Original Research Article 10 November 2012 Pages: 486 - 498

7. Interferon-β in Multiple Sclerosis

   • Terry Madgwick

   Correspondence 10 November 2012 Pages: 499 - 500

8. The author’s reply

   • Keith Tolley
   • David Whynes

   Correspondence 10 November 2012 Pages: 500 - 501

9. Economic Evaluation Techniques in Healthcare

   • Joan Rovira
   • Fernando Antoñanzas

   Correspondence 10 November 2012 Pages: 501 - 505

10. The author’s reply

    • Alan Maynard

    Correspondence 10 November 2012 Pages: 505 - 506